Catherine Longworth is a reporter covering commercial and R&D developments in the medtech industry. A graduate of St. George's, University of London, Catherine holds a BSc in Biomedical Science. Before joining Informa, she worked in the editorial team at Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society, where she wrote and edited for a number of pharmaceutical publications. After gaining experience in the world of scientific publishing, Catherine took the leap to study a postgraduate qualification in journalism. During the course, she carried out placements with local London newspapers, writing general news and building her portfolio by reporting on a wide range of current affairs such as the European migrant crisis, political protests and the London mayoral election. Catherine is passionate about human rights and is fascinated by the innovative nature of the medtech industry and the healthcare advances that have the greatest benefit to mankind. She lives in London and loves music, arts, travel, writing, reading and is always happy to receive recommendations for books or places to travel!
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Catherine Longworth
Device Week, 29 November 2019 – Top Clinical Trial News From AHA & Investment Forecast From Jefferies 2019
In this week's Medtech Insight podcast, deputy editor Reed Miller discusses clinical trial news from the annual American Heart Association (AHA) meeting, and senior reporter Catherine Longworth highlights goings-on at the Jefferies Healthcare Conference in London.
In an example of how so called "digital therapies" can augment traditional drug treatments, Swedish pharma company Orexo has secured exclusive US rights to an AI-based behavioral therapy for the treatment of alcohol use disorder (AUD).
German company Avatera Medical is preparing to take on the surgical robotics market with a new, CE-marked system. The company has announced a strategic plan to build a major production facility for medical robotics in Germany in 2020.
Experts shared three valuable lessons for investors to consider in their commercial strategies during a panel discussion at the recent Jefferies Healthcare Conference in London.
An expert panel of investors at Jefferies Healthcare Conference in London discussed the landscape for private equity investment in health-care businesses.
Terumo is acquiring the vascular therapy company to boost its AAA graft business.